The Effect of Resveratrol on  Surgery-Induced Epidural Fibrosis in Laminectomy Rats

Sun, Peifeng; Miao, Bo; Xin, Hongmei; Zhao, Jinzhu; Xia, Guofeng; Xu, Peng; Hu, Jian; Li, Zhenfeng; Li, Jianmin

doi:https://doi.org/10.1155/2014/574236

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Methods Results Discussion References Copyright Related Articles

Research Article | Open Access

Volume 2014 | Article ID 574236 | https://doi.org/10.1155/2014/574236

The Effect of Resveratrol on Surgery-Induced Epidural Fibrosis in Laminectomy Rats

Peifeng Sun,^1,2Bo Miao,³Hongmei Xin,⁴Jinzhu Zhao,²Guofeng Xia,²Peng Xu,²Jian Hu,²Zhenfeng Li,⁵and Jianmin Li⁵

Academic Editor: Seung-Heon Hong

Received31 Dec 2013

Accepted23 Feb 2014

Published24 Mar 2014

Abstract

Epidural fibrosis (EF) is a common complication for the patients who underwent laminectomy. Recently, EF is thought to cause recurrent postoperative pain after laminectomy. Resveratrol has been shown to exert its anti-inflammatory, antifibrotic, and antiproliferative multifaceted properties. The object of this study was to investigate the effects of resveratrol on the prevention of postlaminectomy EF formation in laminectomy rats. A controlled double-blinded study was performed on 60 healthy adult Sprague-Dawley rats that underwent lumbar laminectomy at the L1-L2 levels. They were divided randomly into 3 groups (1, 2, and 3) of 20 rats each—group 1: resveratrol treatment group; group 2: resveratrol dilution saline treatment group; group 3: sham group (rats underwent laminectomy without treatment). All rats were killed 4 weeks after operation. The Rydell score, hydroxyproline content, vimentin cells density, fibroblasts density, and inflammatory factors expressional levels all suggested better results in resveratrol group than the other two groups. Resveratrol is able to inhibit fibroblasts proliferation, and TGF-β1 and IL-6 expressions and prevent epidural fibrosis in postlaminectomy rat.

1. Introduction

Over one million patients all over the world undergo lumbar laminectomy for treating disc herniation, making it one of the most widely accepted treatments for lumbosacral disorders [1, 2]. Subsequently, failed back surgery syndrome (FBSS) was reported. With the characteristics that patients could suffer from the recurrence of continued pain in the lower posterior trunk and/or lower extremities after lumbar laminectomy, FBSS could lead to the failure of the operation [3]. As early as in 1948, EF was first mentioned to be a scar tissue adjacent to the dura mater following lumbar laminectomy [4]. In 1983, some researchers pointed out that EF might be a contributing factor for FBSS [5].

Until the present, an established EF is still a great challenge to surgeons, and reoperations seem to be helpless and risky [6]. Currently, extensive studies have been tried out on animals with several differing components, such as Adcon-L, free fat grafts, gelfoam, pharmaceutical gels, anti-inflammatory agents, anticancer agents, honey, and others [7–12]. Although some of them have achieved a certain level of success in animals, there is still no optimal solution which has gained success in clinical application or wide acceptance.

Resveratrol (3,5,4′-o-trihydroxystilbene), which is found in grapes, red wine, various other fruits, and medicinal plants, has exerted its variety of biological properties including anticarcinogenic, antioxidant, and anti-inflammatory in a number of previous literatures [13–15]. Also, it can cause vasodilatation and inhibit platelet aggregation [16, 17]. A group of studies have reported that resveratrol is able to prevent the postoperative scar adhesions in animals [16, 18, 19]. After an extensive review, this is the first study on the effect of resveratrol on prevention EF.

In our laminectomy rat model, we investigated whether resveratrol attenuates EF by regulating the expressions of inflammatory factors, such as interleukin 6 (IL6), transforming growth factor-β1 (TGF-β1), and hydroxyproline, which are suggested to be involved in the promotion of EF.

2. Material and Methods

2.1. Animals

60 healthy male Sprague-Dawley rats (mean weight = 280 g) were employed for this study. Experiments were carried out in compliance with the principles of International Laboratory Animal Care and with the European Communities Council Directive (86/809/EEC) and were approved by the local ethical committee. All rats were randomly divided into three groups (twenty rats per group): (1) resveratrol treatment group; (2) saline treatment group; (3) sham group (laminectomy without treatment).

2.2. Reagents and Antibodies

Both resveratrol and β-dimethylaminobenzaldehyde were purchased from Sigma Aldrich Corp., St. Louis, MO, USA. Cal-EX II solution for decalcification and dehydration was purchased from Thermo Fisher Scientific (Waltham, MA, USA), Orangeburg. Reverse transcriptase was purchased from Promega (Madison, WI, USA). Primary anti-vimentin antibody (ab92547) was purchased from abcam. Secondary antibodies were purchased from Santa Cruz.

2.3. Surgery

Lumbar laminectomy was grimly performed according to previous protocol under sterile conditions employing basic surgical tools [20]. Basically, all rats were numbered, respectively, and anesthetized by intraperitoneal injection of 10% chloral hydrate (0.3 mL/100 g body weight). The hairs around the L1 and L2 were shaved and the exposed skin was sterilized. A median incision of dorsal skin was made and the paraspinal muscles were separated on L1-L2 vertebrae. The dura mater of L1 vertebrae was exposed after removing the spinous process and vertebral plate with a rongeur. Gauze was used for homeostasis. The wound site was surgically closed. Close attention was paid not to injure the dura and the nerve roots. Resveratrol (6 mg/kg/day) for group 1 or saline for group 2 was given by the orogastric route to the laminectomy rats for 20 days [18].

2.4. Macroscopic Assessment

Macroscopic assessment was performed 4 weeks after surgery. Five rats were randomly selected from each group and anesthetized. With the help of assistants, the epidural scar adhesion underwent double-blind evaluation. And the results were classified based on the Rydell classification (Table 1) [21].

2.5. Evaluation of Hydroxyproline Content (HPC) in Epidural Scar Tissue

Hydroxyproline content (HPC) analysis was performed 4 weeks after surgery. Five rats were randomly selected from each group and anesthetized. The scar tissue approximately 5 mg wet weight was obtained around the wound site. The content of hydroxyproline of different groups in scar tissue was examined according to the previous protocol [22]. Basically, the samples were lyophilized, ground, and hydrolyzed with 6 mol/L HCl at 110°C for 24 hours. Then 1 mL hydroxyproline developer (β-dimethylaminobenzaldehyde solution) was added to the samples and the standards. The absorbances at 550 nm were read using a spectrophotometer. Finally, the hydroxyproline content (HPC) per milligram of scar tissue was calculated according to the standard curve constructed by the serial concentration of commercial hydroxyproline.

2.6. Histological Analysis

Histological analysis was performed 4 weeks postoperatively. Five rats were randomly selected from each group and anesthetized. Intracardial perfusion with 4% paraformaldehyde and saline was performed. The whole L1 vertebral column including the paraspinal muscles and epidural scar tissue was resected and fixed in 10% phosphate-buffered formaldehyde solution. Cal-Ex II solution was employed to decalcify and dehydrate the samples. After that, they were embedded in paraffin, and 5 μm axial sections of the wound site were stained with hematoxylin and eosin (H&E). The epidural scar adhesion was evaluated under the light microscope (Leica CM3050S, Germany). Three counting areas were selected at the middle and at the margins of the laminectomy sites. The number of fibroblasts cells was calculated. To be more stringent, in order to further quantify the fibroblasts numbers, the immunohistochemistry was performed with application of the monoclonal anti-vimentin antibody and the density of vimentin was evaluated.

2.7. Analysis of IL-6 and TGF-β1 Concentrations

The mRNA analyses of IL-6 and TGF-β1 were performed four weeks postoperatively. Five rats randomly selected from each group were killed, and the scar tissues from the laminectomy sites were collected. Total RNA was extracted using TRIzol reagent and the RNA (2 μg) was transcribed into cDNA by use of AMV Reverse Transcriptase. Quantitative real-time PCR (RTPCR) was performed according to previous study using the Bio-rad MYIQ2 (USA) [23]. Primer sequences were TGF-β1 (148 bp): forward, 5′-GCCCTGCCCCTACATTTGG-3′; reverse, 5′-CTTGCGACCCACGTAGTAGACGAT-3′; IL-6 (131 bp): forward, 5′-ACCCCAACTTCCAATGCTCT-3′; reverse, 5′-TGCCGAGTAGACCTCATAGTGACC-3′; GAPDH (169 bp): forward, 5′-TCACCACCATGGAGAAGGC-3′; reverse, 5′-GCTAAGCAGTTGGTGGTGCA-3′. GAPDH amplification was used as an internal control.

2.8. Statistical Analysis

The statistical analysis was performed using SPSS 13.0 statistical package (SPSS Inc., Chicago, IL, USA). Data are expressed as mean ± standard deviation values. The single factor analysis of variance (ANOVA) and -test were applied to evaluate three independent samples. Statistical significance was assumed at .

3. Results

3.1. Macroscopic Assessment of Epidural Scar Adhesion

The laminectomy was well tolerated by all rats without wound infection, neurological deficit, and cerebrospinal leak.

In the resveratrol group, macroscopic observation showed that soft or weak fibrous adhesion was observed in the laminectomy sites. However, in the laminectomy sites of rats treated with saline or nothing, severe epidural scar adhesions were seen. And it was difficult to dissect the scar adhesions accompanied by bleeding and disruption of the dura mater. The grades of epidural scar adhesion in rats were evaluated according to the Rydell classification (Table 2).

3.2. Hydroxyproline Content (HPC)

HPC concentration in epidural scar tissue was shown in Figure 1. The resveratrol group ( μg/mg) showed a significant reduction compared with that of the saline group ( μg/mg, ) and sham group ( μg/mg, ). The content in saline group showed no significant difference compared with that of sham group ().

3.3. Histological Analysis

In the laminectomy sites of the saline group and sham group, dense epidural scar tissue with widespread adhesions to dura mater and dorsal muscle was observed (Figures 2(b) and 2(c)). However, in the laminectomy sites of the resveratrol group, loose or little scar adhesion was seen (Figure 2(a)).

(a)

(b)

(c)

(d)

(e)

(f)

Figure 2

H&E staining for the epidural scar tissues in the laminectomy sites employed with resveratrol (a), saline (b), and the sham groups (c). (a) Loose scar tissues without adherence (as right arrow pointed) to dura mater were observed in the resveratrol group. (b, c) Dense scar tissues (as right arrow pointed) adhered to dura maters were observed in both saline and sham groups. (d, e, and f) The fibroblasts in the epidural fibrosis were seen by further magnification. The magnification of (a), (b), and (c) was 100x; the magnification of (d), (e), and (f) was 400x. SC: spinal cord, D: dura mater, and EF: epidural fibrosis.

The number of fibroblasts in the resveratrol group () was significantly less than those of the saline group () and sham group (). Representative sections are shown in Figures 2(d), 2(e), and 2(f).

3.4. Effect of Resveratrol on Vimentin

In an effort to be more definitive, an additional immunohistochemistry analysis for vimentin was conducted. Less positive vimentin was observable in the resveratrol group than the saline and sham group (Figure 3).

(a)

(b)

(c)

3.5. Effect of Resveratrolon IL-6 and TGF-β1

In order to find out the effect of resveratrol’s anti-inflammatory activity in EF rat, RTPCR on examining the mRNA expressional levels of both TGF-β1 and IL-6 was conducted. The results of mRNA expressional levels of both TGF-β1 and IL-6 are shown in Figure 4: the resveratrol group was lower than those of the saline group () and sham group (); the expressions between saline group and sham group were not significantly different ().

4. Discussion

Historically, the literature reports that the incidence rate of FBSS among lumbar discectomy patients was 5–30% [24]. Many factors can lead to FBSS, such as improper diagnosis and surgery, disc herniation, spinal stenosis, recurrent or retained disc, and epidural fibrosis [5, 25, 26]. Epidural fibrosis, as an epidural scar tissue, is characterized by extracellular matrix protein deposition, fibroblast accumulation, and distortion of normal tissue architecture due to inflammation. It can cause extensive adhesions around the dura mater and squeeze the nerve roots [23, 27]. Besides, it is a risk factor for surgeons to perform repeat operations, as it may lead to dura tearing, excessive bleeding, and nerve root injury [12]. Therefore, it is important to reduce the three aforementioned factors in order to effectively prevent EF.

In the present study using sixty EF rats, resveratrol has demonstrated its high efficacy in multifaceted suppression of the factors. The data showed significant decrease of hydroxyproline levels in scar tissues. The Rydell score showed a better result treated with resveratrol than the other 2 groups. Both H&E staining and further immunohistochemistry analysis for vimentin enhanced our hypothesis. RTPCR analyses showed a significant decrease of both IL-6 and TGF-β1. All of the above support resveratrol’s antifibrotic, anti-inflammatory, and antiproliferative roles. Literatures also support our theory by reporting on resveratrol’s antifibrotic, anti-inflammatory, and antiproliferative properties in other surgery-induced adhesions [15, 16, 18]. These studies and present data may explain some if not all of the possible mechanisms that make resveratrol effective in preventing or suppressing EF.

After further extensive literature reviews, we feel confident to report that the present study may be one of the first studies studying resveratrol’s suppressive effects on EF by down regulating inflammatory expressional levels such as IL-6 and TGF-β1 and also reducing hydroxyproline deposition in rats. Undoubtedly, in further research, more research on drug safety, effectively safe concentration, long-term effects, and possible side and adverse effects of resveratrol is needed before clinical trials and application.

Conflict of Interests

There are no potential conflict of interests and financial activities related to the present paper to disclose.

Authors’ Contribution

Peifeng Sun and Bo Miao contributed equally to this work.

References

D. Fiume, S. Sherkat, G. M. Callovini, G. Parziale, and G. Gazzeri, “Treatment of the failed back surgery syndrome due to lumbo-sacral epidural fibrosis,” Acta Neurochirurgica. Supplement, vol. 64, pp. 116–118, 1995.
View at: Google Scholar
C. V. Burton, “Lumbosacral arachnoiditis,” Spine, vol. 3, no. 1, pp. 24–30, 1978.
View at: Google Scholar
J. Cauchoix, C. Ficat, and B. Girard, “Repeat surgery after disc excision,” Spine, vol. 3, no. 3, pp. 256–259, 1978.
View at: Google Scholar
J. A. Key and L. T. Ford, “Experimental intervertebral disc-lesions,” The Journal of Bone and Joint Surgery, vol. 30, no. 3, pp. 621–630, 1948.
View at: Google Scholar
E. B. Siqueira, L. I. Kranzler, and D. D. Dharkar, “Fibrosis of the dura mater: a cause of “failed back” syndrome,” Surgical Neurology, vol. 19, no. 2, pp. 168–170, 1983.
View at: Google Scholar
G. Cruccu, T. Z. Aziz, L. Garcia-Larrea et al., “EFNS guidelines on neurostimulation therapy for neuropathic pain,” European Journal of Neurology, vol. 14, no. 9, pp. 952–970, 2007.
View at: Publisher Site | Google Scholar
G. G. Gill, M. Scheck, E. T. Kelley, and J. J. Rodrigo, “Pedicle fat grafts for the prevention of scar in low-back surgery. A preliminary report on the first 92 cases,” Spine, vol. 10, no. 7, pp. 662–667, 1985.
View at: Google Scholar
M. A. Sandoval and D. Hernandez-Vaquero, “Preventing peridural fibrosis with nonsteroidal anti-inflammatory drugs,” European Spine Journal, vol. 17, no. 3, pp. 451–455, 2008.
View at: Publisher Site | Google Scholar
B. Cemil, K. Tun, E. Kaptanoglu et al., “Use of pimecrolimus to prevent epidural fibrosis in a postlaminectomy rat model: laboratory investigation,” Journal of Neurosurgery: Spine, vol. 11, no. 6, pp. 758–763, 2009.
View at: Publisher Site | Google Scholar
G. G. Gill, L. Sakovich, and E. Thompson, “Pedicle fat grafts for the prevention of scar formation after laminectomy. An experimental study in dogs,” Spine, vol. 4, no. 2, pp. 176–186, 1979.
View at: Google Scholar
J. Barbera, J. Gonzalez, and J. Esquerdo, “Prophylaxis of the laminectomy membrane. An experimental study in dogs,” Journal of Neurosurgery, vol. 49, no. 3, pp. 419–424, 1978.
View at: Google Scholar
M. R. Farrokhi, M. Vasei, S. Fareghbal, and A. Bakhtazad, “Effect of honey on peridural fibrosis formation after laminectomy in rats: a novel experimental study,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 504967, 6 pages, 2011.
View at: Publisher Site | Google Scholar
A. A. E. Bertelli, L. Giovannini, D. Giannessi et al., “Antiplatelet activity of synthetic and natural resveratrol in red wine,” International Journal of Tissue Reactions, vol. 17, no. 1, pp. 1–3, 1995.
View at: Google Scholar
S. Rotondo, G. Rajtar, S. Manarini et al., “Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function,” British Journal of Pharmacology, vol. 123, no. 8, pp. 1691–1699, 1998.
View at: Publisher Site | Google Scholar
S. Kaplan, J. A. Morgan, G. Bisleri et al., “Effects of resveratrol in storage solution on adhesion molecule expression and nitric oxide synthesis in vein grafts,” Annals of Thoracic Surgery, vol. 80, no. 5, pp. 1773–1778, 2005.
View at: Publisher Site | Google Scholar
Y. Üstün, Y. Engin-Üstün, A. Ovayolu, M. M. Meydanli, I. Temel, and A. Kafkasli, “The effect of resveratrol on prevention of the development of postoperative adhesions in a rat model,” Gynecological Endocrinology, vol. 23, no. 9, pp. 518–522, 2007.
View at: Publisher Site | Google Scholar
L.-M. Hung, J.-K. Chen, S.-S. Huang, R.-S. Lee, and M.-J. Su, “Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes,” Cardiovascular Research, vol. 47, no. 3, pp. 549–555, 2000.
View at: Publisher Site | Google Scholar
S. Orçan, A. Seven, H. Isık et al., “Resveratrol inhibits postoperative adhesion formation in a rat uterine horn adhesion model,” Human Fertility (Cambridge), vol. 15, no. 4, pp. 217–220, 2012.
View at: Google Scholar
G. Sogutlu, A. B. Karabulut, C. Ara et al., “The effect of resveratrol on surgery-induced peritoneal adhesions in an experimental model,” Cell Biochemistry and Function, vol. 25, no. 2, pp. 217–220, 2007.
View at: Publisher Site | Google Scholar
C. Zhang, X. Kong, H. Zhou et al., “An experimental novel study: angelica sinensis prevents epidural fibrosis in laminectomy rats via downregulation of hydroxyproline, IL-6, and TGF- $β$ 1,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 291814, 7 pages, 2013.
View at: Publisher Site | Google Scholar
N. Rydell, “Decreased granulation tissue reaction after installment of hyaluronic acid,” Acta Orthopaedica Scandinavica, vol. 41, no. 3, pp. 307–311, 1970.
View at: Google Scholar
N. Fukui, T. Tashiro, H. Hiraoka, H. Oda, and K. Nakamura, “Adhesion formation can be reduced by the suppression of transforming growth factor-β1 activity,” Journal of Orthopaedic Research, vol. 18, no. 2, pp. 212–219, 2000.
View at: Google Scholar
C. Zhang, X. Kong, G. Ning et al., “All-trans retinoic acid prevents epidural fibrosis through NF- $κ$ B signaling pathway in post-laminectomy rats,” Neuropharmacology, vol. 79C, pp. 275–281, 2013.
View at: Google Scholar
B. Jonsson and B. Stromqvist, “Repeat decompression of lumbar nerve roots. A prospective two-year evaluation,” Journal of Bone and Joint Surgery B, vol. 75, no. 6, pp. 894–897, 1993.
View at: Google Scholar
R. B. North, J. N. Campbell, C. S. James et al., “Failed back surgery syndrome: 5-year follow-up in 102 patients undergoing repeated operation,” Neurosurgery, vol. 28, no. 5, pp. 685–691, 1991.
View at: Google Scholar
C. W. Slipman, C. H. Shin, R. K. Patel et al., “Etiologies of failed back surgery syndrome,” Pain Medicine, vol. 3, no. 3, pp. 200–214, 2002.
View at: Publisher Site | Google Scholar
C. Zhang, X. Kong, C. Liu et al., “ERK2 small interfering RNAs prevent epidural fibrosis via the efficient inhibition of collagen expression and inflammation in laminectomy rats,” Biochemical and Biophysical Research Communications, vol. 444, no. 3, pp. 395–400, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2014 Peifeng Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

5339

Downloads

1155

Citations